McKesson EBITDA 2010-2024 | MCK
McKesson annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- McKesson EBITDA for the quarter ending September 30, 2024 was $0.741B, a 33.12% decline year-over-year.
- McKesson EBITDA for the twelve months ending September 30, 2024 was $4.116B, a 15.95% decline year-over-year.
- McKesson 2024 annual EBITDA was $4.544B, a 8.92% decline from 2023.
- McKesson 2023 annual EBITDA was $4.989B, a 78.31% increase from 2022.
- McKesson 2022 annual EBITDA was $2.798B, a 171.54% decline from 2021.
McKesson Annual EBITDA
(Millions of US $) |
| 2024 |
$4,544 |
| 2023 |
$4,989 |
| 2022 |
$2,798 |
| 2021 |
$-3,911 |
| 2020 |
$3,550 |
| 2019 |
$3,914 |
| 2018 |
$3,930 |
| 2017 |
$8,322 |
| 2016 |
$4,438 |
| 2015 |
$4,226 |
| 2014 |
$3,174 |
| 2013 |
$2,928 |
| 2012 |
$2,617 |
| 2011 |
$2,317 |
| 2010 |
$2,482 |
| 2009 |
$1,637 |
McKesson Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
$741 |
| 2024-06-30 |
$1,198 |
| 2024-03-31 |
$1,376 |
| 2023-12-31 |
$801 |
| 2023-09-30 |
$1,108 |
| 2023-06-30 |
$1,259 |
| 2023-03-31 |
$1,141 |
| 2022-12-31 |
$1,389 |
| 2022-09-30 |
$1,275 |
| 2022-06-30 |
$1,184 |
| 2022-03-31 |
$795 |
| 2021-12-31 |
$483 |
| 2021-09-30 |
$734 |
| 2021-06-30 |
$786 |
| 2021-03-31 |
$1,237 |
| 2020-12-31 |
$-7,003 |
| 2020-09-30 |
$960 |
| 2020-06-30 |
$895 |
| 2020-03-31 |
$1,126 |
| 2019-12-31 |
$689 |
| 2019-09-30 |
$867 |
| 2019-06-30 |
$868 |
| 2019-03-31 |
$1,074 |
| 2018-12-31 |
$982 |
| 2018-09-30 |
$930 |
| 2018-06-30 |
$928 |
| 2018-03-31 |
$988 |
| 2017-12-31 |
$1,068 |
| 2017-09-30 |
$1,014 |
| 2017-06-30 |
$860 |
| 2017-03-31 |
$4,986 |
| 2016-12-31 |
$1,035 |
| 2016-09-30 |
$1,087 |
| 2016-06-30 |
$1,214 |
| 2016-03-31 |
$962 |
| 2015-12-31 |
$1,140 |
| 2015-09-30 |
$1,176 |
| 2015-06-30 |
$1,160 |
| 2015-03-31 |
$1,172 |
| 2014-12-31 |
$1,048 |
| 2014-09-30 |
$1,045 |
| 2014-06-30 |
$961 |
| 2014-03-31 |
$845 |
| 2013-12-31 |
$656 |
| 2013-09-30 |
$856 |
| 2013-06-30 |
$817 |
| 2013-03-31 |
$865 |
| 2012-12-31 |
$629 |
| 2012-09-30 |
$733 |
| 2012-06-30 |
$701 |
| 2012-03-31 |
$767 |
| 2011-12-31 |
$629 |
| 2011-09-30 |
$614 |
| 2011-06-30 |
$607 |
| 2011-03-31 |
$767 |
| 2010-12-31 |
$421 |
| 2010-09-30 |
$535 |
| 2010-06-30 |
$594 |
| 2010-03-31 |
$697 |
| 2009-12-31 |
$635 |
| 2009-09-30 |
$580 |
| 2009-06-30 |
$570 |
| 2009-03-31 |
$609 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$78.151B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
